<?xml version="1.0" encoding="UTF-8"?>
<p id="p0681" num="0681" sourceFile="EPÂ 1648878B1.xml">Methods for assaying compounds capable of inhibiting VR1 are known to those skilled in the art, for example, those methods disclosed in 
  <patcit id="pcit0044" dnum="US6239267B">
    <text>U.S. Patent No. 6,239,267 to Duckworth et al.</text>
  </patcit>
  <i>;</i>
  <patcit id="pcit0045" dnum="US6406908B">
    <text>U.S. Patent No. 6,406,908 to McIntyre et al.</text>
  </patcit>
  <i>;</i> or 
  <patcit id="pcit0046" dnum="US6335180B">
    <text>U.S.
      <!-- EPO <DP n="204"> --> Patent No. 6,335,180 to Julius et al.
    </text>
  </patcit>
  <i>.</i> The results of these assays will demonstrate that Piperidine Compounds bind to and modulate the activity of VR1.
</p>
